Back to Awarded Treatment Trials


Awarded Trial: 02T-156

Grant ID

02T-156

Illness

Schizophrenia

Primary Drug/Intervention

Panax ginseng

Primary Dosage

100 mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Chiu

Sample Size

60

Duration of Study Period for Each Subject

8 weeks

Outcome Measurements

SANS, HAMD-D, BPRS, PANSS, Cognitive battery

Results

Forty-two patients completed the trial. The crossover design was unable to rule out carryover effects in those subjects that received ginseng first. Excluding data from the crossover design, patients receiving ginseng showed a significant reduction in SANS, HAM-D, total PANSS, and PANSS negative subscale score. There was no effect on cognitive measures.

Publication

N/A

Link

N/A

PI Name

Simon Chiu

Degree

MD

Center

MSA LTD.

Institution

University of Western Ontario Research Park

Address

100 Collip Circle, Suite 230 A

City or Town

London

State or Province

Ontario

Zip or Postal Code

N6G 4X8

Country

Canada

Email Address

schiu3207@rogers.com